CD32 Antibodies

Santa Cruz Biotechnology features a diverse variety of CD32 monoclonal antibodies for advanced research in immunology and cell biology. CD32 monoclonal antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CD32, also known as FcγRII, plays a critical role in the immune response by mediating the binding of immunoglobulin G (IgG) to immune cells, influencing processes such as phagocytosis and antibody-dependent cellular cytotoxicity. Understanding CD32's function in immune signaling and homeostasis maintenance has significant implications for therapeutic development and disease research. CD32 monoclonal antibodies enable precise detection and analysis of protein expression patterns across different cell types and tissues. Researchers can investigate CD32's role in various physiological and pathological conditions, from autoimmune disorders to cancer. CD32 monoclonal antibodies support detailed examination of cellular signaling pathways and protein-protein interactions. Santa Cruz Biotechnology monoclonal antibodies for CD32 contribute to advancing scientific understanding of immune system regulation and potential therapeutic applications.